Deepak B Salunke

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

Journal of medicinal chemistry

ACS omega

ACS pharmacology & translational science

Expert opinion on therapeutic patents

Panjab University

National Chemical Laboratory CSIR (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Panjab University Nov 27 2014

India

Assistant Professor :: Chemistry

SAI Life Sciences Ltd Pune Apr 01 2014 - Nov 24 2014

India

Senior Research Scientist :: Medicinal Chemistry

University of Kansas Mar 31 2013 - Mar 30 2014

United States

Assistant Research Professor :: Higuchi Biosciences Center (HBC)

University of Kansas Nov 10 2010 - Mar 30 2013

United States

Postdoctoral Research Associate :: Medicinal Chemistry

Advinus Therapeutics Ltd Pune May 04 2008 - Sep 19 2009

India

Research Scientist-II :: Discovery Chemistry

Education History

National Chemical Laboratory CSIR

India

PHD :: Chemistry

Ahmednagar College

India

MSC :: Chemistry

Publications

Kushvinder Kumar, Binita Sihag, Madhuri T Patil, Rahul Singh, Isaac G Sakala, Yoshikazu Honda-Okubo, Kamal Nain Singh, Nikolai Petrovsky, Deepak B Salunke
Design and Synthesis of Polyphenolic Imidazo[4,5- c ]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity. ACS pharmacology & translational science 7 (7) (2024)
Deepender Kaushik, Arshpreet Kaur, Madhuri T Patil, Binita Sihag, Sakshi Piplani, Isaac Sakala, Yoshikazu Honda-Okubo, Saravanan Ramakrishnan, Nikolai Petrovsky, Deepak B Salunke
Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist. Journal of medicinal chemistry (2024)
Aashima Batra, Manpreet Kaur, Deepender Kaushik, Simran Kaur, Madhuri T Patil, Vinod D Chaudhari, Subash Chandra Sahoo, Deepak B Salunke
Synthesis of Triazolo[4',5':4,5]furo[2,3- c ]pyridine via Post Modification of an Unusual Groebke-Blackburn-Bienaymé Multicomponent Reaction. ACS omega 9 (27) (2024)
Kushvinder Kumar, Binita Sihag, Madhuri T Patil, Rahul Singh, Isaac G Sakala, Yoshikazu Honda-Okubo, Kamal Nain Singh, Nikolai Petrovsky, Deepak B Salunke
Design and Synthesis of Polyphenolic Imidazo[4,5- c ]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity. ACS pharmacology & translational science 7 (7) (2024)
Aashima Batra, Manpreet Kaur, Deepender Kaushik, Simran Kaur, Madhuri T Patil, Vinod D Chaudhari, Subash Chandra Sahoo, Deepak B Salunke
Synthesis of Triazolo[4',5':4,5]furo[2,3- c ]pyridine via Post Modification of an Unusual Groebke-Blackburn-Bienaymé Multicomponent Reaction. ACS omega 9 (27) (2024)
Deepender Kaushik, Arshpreet Kaur, Madhuri T Patil, Binita Sihag, Sakshi Piplani, Isaac Sakala, Yoshikazu Honda-Okubo, Saravanan Ramakrishnan, Nikolai Petrovsky, Deepak B Salunke
Structure-Activity Relationships toward the Identification of a High-Potency Selective Human Toll-like Receptor-7 Agonist. Journal of medicinal chemistry 67 (10) (2024)
Ravinder Kumar, Rahul Singh, Ayla das Chagas Almeida, Juliana da Trindade Granato, Ari Sérgio de Oliveira Lemos, Kushvinder Kumar, Madhuri T Patil, Adilson D da Silva, Ambadas B Rode, Elaine S Coimbra, Deepak B Salunke
Imidazo[1,2- a ]pyrimidine as a New Antileishmanial Pharmacophore against Leishmania amazonensis Promastigotes and Amastigotes. ACS omega 8 (43) (2023)
Deepak B Salunke, Dennis C Liotta
Call for Papers: Medicinal Chemistry of Next Generation Vaccine Adjuvants. Journal of medicinal chemistry (2023)
Jyoti Rathee, Rohini Kanwar, Laxmi Kumari, Sandip V Pawar, Shikha Sharma, Md Ehesan Ali, Deepak B Salunke, Surinder Kumar Mehta
Development of nanostructured lipid carriers as a promising tool for methotrexate delivery: physicochemical and in vitro evaluation. Journal of biomolecular structure & dynamics (2022)
Deepender Kaushik, Juliana T Granato, Gilson C Macedo, Paula R B Dib, Sakshi Piplani, Johnson Fung, Adilson D da Silva, Elaine Soares Coimbra, Nikolai Petrovsky, Deepak B Salunke
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. The Journal of pharmacy and pharmacology 73 (9) (2021)
Rahul Singh, Ravinder Kumar, Mallesh Pandrala, Parleen Kaur, Saloni Gupta, Dhanir Tailor, Sanjay V Malhotra, Deepak B Salunke
Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation. Archiv der Pharmazie 354 (7) (2021)
Deepender Kaushik, Simran Dhingra, Madhuri T Patil, Sakshi Piplani, Varun Khanna, Yoshikazu Honda-Okubo, Lei Li, Johnson Fung, Isaac G Sakala, Deepak B Salunke, Nikolai Petrovsky
BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant. Human vaccines & immunotherapeutics 16 (8) (2020)
Arshpreet Kaur, Deepender Kaushik, Sakshi Piplani, Surinder Kumar Mehta, Nikolai Petrovsky, Deepak B Salunke
TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects. Journal of medicinal chemistry 64 (1) (2020)
Poonam Singla, Priyanka Dalal, Mahaldeep Kaur, Geeta Arya, Surendra Nimesh, Rachna Singh, Deepak B Salunke
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections. Journal of medicinal chemistry 61 (22) (2018)
Arshpreet Kaur, Deepika Kannan, Surinder K Mehta, Shailja Singh, Deepak B Salunke
Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review. Expert opinion on therapeutic patents 28 (11) (2018)
Arshpreet Kaur, null Poonam, Madhuri T Patil, Surinder K Mehta, Deepak B Salunke
An efficient and scalable synthesis of potent TLR2 agonistic PAM 2 CSK 4 . RSC advances 8 (18) (2018)

Deepak B Salunke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Deepak B Salunke